Avobenzone incorporation in a diverse range of Ru(ii) scaffolds produces potent potential antineoplastic agents

Raphael T. Ryan, Dmytro Havrylyuk, Kimberly C. Stevens, L. Henry Moore, Doo Young Kim, Jessica S. Blackburn, David K. Heidary, John P. Selegue, Edith C. Glazer

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Four structurally distinct classes of polypyridyl ruthenium complexes containing avobenzone exhibited low micromolar and submicromolar potencies in cancer cells, and were up to 273-fold more active than the parent ligand. Visible light irradiation enhanced the cytotoxicity of some complexes, making them promising candidates for combined chemo-photodynamic therapy.

Original languageEnglish
Pages (from-to)12161-12167
Number of pages7
JournalDalton Transactions
Volume49
Issue number35
DOIs
StatePublished - Sep 21 2020

Bibliographical note

Funding Information:
We gratefully acknowledge the National Institutes of Health (Grant GM107586 to E. C. G. and DP2CA228043 to J. S. B) and the Kentucky Science & Engineering Foundation (KSEF-4003-RDE-020 to J. P. S. and E. C. G.) for the support of this research. LC MS data was obtained using an instrument kindly shared by Dr Steven Van Lanen (UKY College of Pharmacy) and supported in part by the University of Kentucky Vice President for Research.

Publisher Copyright:
© 2020 The Royal Society of Chemistry.

ASJC Scopus subject areas

  • Inorganic Chemistry

Fingerprint

Dive into the research topics of 'Avobenzone incorporation in a diverse range of Ru(ii) scaffolds produces potent potential antineoplastic agents'. Together they form a unique fingerprint.

Cite this